HanchorBio, a clinical-stage biotechnology company focusing on immune-oncology and dedicated to developing next-generation ...

High IL1RAP protein expression on tumor cells is linked to poor survival in PDAC patients treated with chemotherapy, while this patient group has the longest survival when treated with nadunolimab in ...

With this new information, the researchers created a new drug called SapC-DOPG. This drug targets a special fat found on the ...

PhotonPharma , a cancer immunotherapy company developing a scalable autologous therapy platform, Innocell™, announced that ...

Johns Hopkins scientists discovered a way to convert “immune-cold” tumors into “immune-hot” ones by activating key immune ...

Pancreatic ductal adenocarcinoma (PDAC) is one of the most aggressive forms of cancer, with fewer than 10 percent of patients ...

The University of Cincinnati Cancer Center’s Ahmet Kaynak examined the unique tumor microenvironment of pancreatic ductal adenocarcinoma cells, identified one of the key proteins that aids tumor ...

Catalent gains global rights to evaluate certepetide and its analogs for use as SMARTag® payloads across multiple ADCs designed to address ...

In this article, we will be taking a look at the 15 Best Biotech Penny Stocks to Invest in Right Now. I-Mab stands second among them. I-Mab (NASDAQ:IMAB) is a U.S.-based biotechnology company focused ...

Advances in tissue-based technology in the past few years have created unprecedented opportunities to identify biomarkers of disease processes, especially within oncology by using multi-omics ...

lncRNAs and tumor microenvironment dynamics lncRNAs mediate the interactions between tumor cells and their surrounding microenvironment, influencing several aspects of tumor behavior. These ...

The complex tumor microenvironment (TME) in osteosarcoma is emerging as a critical factor in disease progression and treatment resistance. Recent insights highlight the intricate interplay between ...